FI955795A0 - Aromaattisia asetyylikoliiniesteraasin inhibiittoreita - Google Patents
Aromaattisia asetyylikoliiniesteraasin inhibiittoreitaInfo
- Publication number
- FI955795A0 FI955795A0 FI955795A FI955795A FI955795A0 FI 955795 A0 FI955795 A0 FI 955795A0 FI 955795 A FI955795 A FI 955795A FI 955795 A FI955795 A FI 955795A FI 955795 A0 FI955795 A0 FI 955795A0
- Authority
- FI
- Finland
- Prior art keywords
- aromatic
- acetylcholinesterase inhibitors
- compounds
- acetylcholinesterase
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/35—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/361—Preparation of halogenated hydrocarbons by reactions involving a decrease in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/62—Halogen-containing esters
- C07C69/63—Halogen-containing esters of saturated acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93401431A EP0627400A1 (en) | 1993-06-04 | 1993-06-04 | Aromatic acetylcholinesterase inhibitors |
| PCT/US1994/004957 WO1994029255A1 (en) | 1993-06-04 | 1994-05-05 | Aromatic acetylcholinesterase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI955795A FI955795A (fi) | 1995-12-01 |
| FI955795A0 true FI955795A0 (fi) | 1995-12-01 |
Family
ID=8214719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI955795A FI955795A0 (fi) | 1993-06-04 | 1995-12-01 | Aromaattisia asetyylikoliiniesteraasin inhibiittoreita |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5663448A (fi) |
| EP (2) | EP0627400A1 (fi) |
| JP (1) | JP3735372B2 (fi) |
| KR (1) | KR960702820A (fi) |
| CN (1) | CN1124953A (fi) |
| AT (1) | ATE174895T1 (fi) |
| AU (1) | AU676578B2 (fi) |
| CA (1) | CA2164303C (fi) |
| DE (1) | DE69415522T2 (fi) |
| DK (1) | DK0701546T3 (fi) |
| ES (1) | ES2127396T3 (fi) |
| FI (1) | FI955795A0 (fi) |
| HU (1) | HUT73484A (fi) |
| IL (1) | IL109863A (fi) |
| NO (1) | NO306058B1 (fi) |
| NZ (1) | NZ267221A (fi) |
| TW (1) | TW385247B (fi) |
| WO (1) | WO1994029255A1 (fi) |
| ZA (1) | ZA943787B (fi) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6017887A (en) * | 1995-01-06 | 2000-01-25 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
| US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
| US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| US20060142186A1 (en) * | 2004-12-23 | 2006-06-29 | Voyager Pharmaceutical Corporation | Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease |
| US20060194723A1 (en) * | 2005-02-28 | 2006-08-31 | Rabinoff Michael D | Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| EP2117540A1 (en) | 2007-03-01 | 2009-11-18 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
| JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
| SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| EP2533645B1 (en) * | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| CN102826985B (zh) * | 2012-09-18 | 2015-08-19 | 厦门大学 | 一种1-(3,4,5-三羟基)苯基-1-烷基酮的制备方法 |
| EP2919788A4 (en) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA |
| EP2968237A4 (en) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION |
| DK2968220T3 (da) | 2013-03-15 | 2021-06-14 | Agenebio Inc | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
| BR112017025031B1 (pt) | 2015-05-22 | 2023-03-21 | Agenebio, Inc | Composições farmacêuticas de liberação prolongada de levetiracetam |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI783042A (fi) * | 1977-10-07 | 1979-04-08 | Science Union & Cie | Foerfarande foer framstaellning av nya derivat av arylalkankarboxylsyror |
| US4835099A (en) * | 1986-11-20 | 1989-05-30 | Becton, Dickinson And Company | Signal enhancement in immunoassay by modulation of enzymatic catalysis |
| DE3725941A1 (de) * | 1987-08-05 | 1989-02-16 | Hoechst Ag | Ester von arylperfluoralkylcarbinolen, verfahren zur herstellung dieser verbindungen und der zugrundeliegenden arylbisperfluoralkylcarbinole |
| JP2509282B2 (ja) * | 1987-09-24 | 1996-06-19 | 鹿島石油株式会社 | 光学活性なジフルオロアルコ―ル誘導体 |
| NZ231735A (en) * | 1988-12-23 | 1992-04-28 | Ici Plc | Alcohol/ether derivatives, preparation and pharmaceutical compositions thereof |
| US5214069A (en) * | 1988-12-23 | 1993-05-25 | Imperial Chemical Industries Plc | Alcohol and ether derivatives |
| JPH02200646A (ja) * | 1989-01-31 | 1990-08-08 | Nippon Oil & Fats Co Ltd | フルオロアルキル基含有芳香族誘導体及びその製造方法 |
| EP0403713A1 (en) * | 1989-06-22 | 1990-12-27 | Merrell Dow Pharmaceuticals Inc. | Novel acetylcholinesterase inhibitors |
| DE3927049A1 (de) * | 1989-08-16 | 1991-02-21 | Sandoz Ag | Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung |
| EP0611769A1 (en) * | 1993-02-16 | 1994-08-24 | Merrell Dow Pharmaceuticals Inc. | Silylated acetylcholinesterase inhibitors |
-
1993
- 1993-06-04 EP EP93401431A patent/EP0627400A1/en not_active Withdrawn
-
1994
- 1994-05-05 AT AT94917916T patent/ATE174895T1/de not_active IP Right Cessation
- 1994-05-05 DK DK94917916T patent/DK0701546T3/da active
- 1994-05-05 JP JP50177495A patent/JP3735372B2/ja not_active Expired - Fee Related
- 1994-05-05 ES ES94917916T patent/ES2127396T3/es not_active Expired - Lifetime
- 1994-05-05 CA CA002164303A patent/CA2164303C/en not_active Expired - Fee Related
- 1994-05-05 KR KR1019950705440A patent/KR960702820A/ko not_active Application Discontinuation
- 1994-05-05 DE DE69415522T patent/DE69415522T2/de not_active Expired - Lifetime
- 1994-05-05 AU AU69442/94A patent/AU676578B2/en not_active Ceased
- 1994-05-05 NZ NZ267221A patent/NZ267221A/en unknown
- 1994-05-05 HU HU9503452A patent/HUT73484A/hu unknown
- 1994-05-05 EP EP94917916A patent/EP0701546B1/en not_active Expired - Lifetime
- 1994-05-05 CN CN94192338A patent/CN1124953A/zh active Pending
- 1994-05-05 WO PCT/US1994/004957 patent/WO1994029255A1/en active IP Right Grant
- 1994-05-05 US US08/557,120 patent/US5663448A/en not_active Expired - Lifetime
- 1994-05-30 ZA ZA943787A patent/ZA943787B/xx unknown
- 1994-05-31 TW TW083104979A patent/TW385247B/zh active
- 1994-06-02 IL IL10986394A patent/IL109863A/en not_active IP Right Cessation
-
1995
- 1995-12-01 FI FI955795A patent/FI955795A0/fi unknown
- 1995-12-01 NO NO954896A patent/NO306058B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU6944294A (en) | 1995-01-03 |
| NO954896L (no) | 1996-02-02 |
| EP0627400A1 (en) | 1994-12-07 |
| ZA943787B (en) | 1995-01-30 |
| WO1994029255A1 (en) | 1994-12-22 |
| HU9503452D0 (en) | 1996-01-29 |
| EP0701546B1 (en) | 1998-12-23 |
| JPH08511019A (ja) | 1996-11-19 |
| DE69415522T2 (de) | 1999-06-02 |
| ES2127396T3 (es) | 1999-04-16 |
| NO306058B1 (no) | 1999-09-13 |
| NZ267221A (en) | 1997-11-24 |
| HUT73484A (en) | 1996-08-28 |
| FI955795A (fi) | 1995-12-01 |
| EP0701546A1 (en) | 1996-03-20 |
| JP3735372B2 (ja) | 2006-01-18 |
| DE69415522D1 (de) | 1999-02-04 |
| CA2164303A1 (en) | 1994-12-22 |
| AU676578B2 (en) | 1997-03-13 |
| ATE174895T1 (de) | 1999-01-15 |
| IL109863A0 (en) | 1994-10-07 |
| DK0701546T3 (da) | 1999-08-16 |
| TW385247B (en) | 2000-03-21 |
| NO954896D0 (no) | 1995-12-01 |
| IL109863A (en) | 1998-12-27 |
| KR960702820A (ko) | 1996-05-23 |
| US5663448A (en) | 1997-09-02 |
| CN1124953A (zh) | 1996-06-19 |
| CA2164303C (en) | 2000-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0701546T3 (da) | Aromatiske acetylchlolinesteraseinhibitorer | |
| ATE152725T1 (de) | Silylierte acetylcholinesterase inhibitoren | |
| DE69427869D1 (de) | Botulinumtoxine zur behandlung von hyperhydrosis | |
| MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
| ES2106965T3 (es) | Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa. | |
| DE69429208D1 (de) | Substanz P Antagonisten zur Behandlung von Erbrechen | |
| DE69403906D1 (de) | Methode zur behandlung von spontan brennbaren katalysatoren | |
| MX9302931A (es) | Nuevas 4-aza-5&-colestan-onas 7b-substituidas como inhibidores de 5&-reductasa. | |
| DE69432626D1 (de) | Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen | |
| WO1996031208A3 (de) | Verwendung von substituierten piperidin- oder pyrrolidinverbindungen zur behandlung von sigma-rezeptor modulierten krankheiten | |
| DE59305800D1 (de) | Werkzeug zur behandlung von oberflächen von bauteilen | |
| ATE262527T1 (de) | Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo(2.1.5-cd)indolizin-derivate |